On March 21, CCTV-2's Consumption Perspective unveiled a silent revolution in RNA omics decoding—inside the laboratories of Shenzhen OxTium Biomedical Technology Co., Ltd., the GeneLLM™️ bioscience large model acts like a "biological detective," capturing hidden clues of disease from trillions of RNA molecular signals. This technology not only transforms Alzheimer's disease (AD) early warning from a "needle in a haystack" into a computable scientific proposition but also propels life science research from "hypothesis-driven" to "data-intelligence-driven"—a historic leap.
GeneLLM™️ Technological Breakthroughs: Three Innovations Defining New Standards for Bioscience AI
1. 1.5-Billion-Parameter Large Model: Decoding the Code of Life with Multi-Dimensional Data
As China's first bioscience large model achieving cross-omics intelligent integration, GeneLLM™️ has completed pre-training with 1.5 billion parameters, learning deep patterns from over 3.5 trillion base sequences. It deeply integrates genome, transcriptome, proteome, and other full-dimensional life data to build a computable life system model. With hundred-fold efficiency, it breaks through traditional research paradigms, providing a next-generation underlying technology engine for ecosystem health assessment, disease mechanism analysis, molecular design breeding, and other scenarios.
Typical case: In early AD warning, GeneLLM™️ captures microscopic signals from cfRNA sequencing data that traditional methods miss, providing strong technical support for disease risk prediction.
2. Clinical-Grade Performance Validation: From Hypothesis-Driven to Medical Decision-Making Genetic Benchmarks
OxTium Technology deeply collaborates with top domestic medical diagnostic institutions and leading clinical laboratories. Through strategic industry-academia-research partnerships, the model's performance has been validated on over 10,000 real clinical samples. Currently, GeneLLM™️ has demonstrated significant potential in cancer genomics and early risk assessment of Alzheimer's disease. As the technology matures, more diseases will be able to achieve breakthroughs in basic research through this platform, greatly improving innovation efficiency for enterprises and research institutions while reducing industrialization costs.
3. Bioford™️ Platform: Hundred-Model Synergy, Defining a New AI Foundation for Bioscience
OxTium Technology's one-stop bioscience research platform—Bioford™️—centered on GeneLLM™️, will pioneer a new "AI for Science" paradigm. The platform deeply integrates genomics, AI algorithms, and bioinformatics to build full-stack solutions from basic research to industrial application. With a matrix layout of hundreds of vertical models, it seamlessly covers diverse scenarios such as medical diagnostics, biomanufacturing, and environmental monitoring, supporting modular task precise adaptation and demonstrating unprecedented research flexibility.
Through the "pre-training-fine-tuning" paradigm, platform models can intelligently transfer cross-domain knowledge, enabling cutting-edge exploration in basic research, deep breakthroughs in medicine, and efficiency revolutions in biomanufacturing. For different user groups, lightweight inference terminals and customized solutions are provided, significantly lowering technical barriers and allowing small and medium-sized research institutions to share the dividends of AI research.
Industrial empowerment has yielded tangible results: The platform-driven "Jinling Reagent Kit" and other domestic alternatives have been successfully implemented, effectively breaking the bottleneck of biological reagent "stranglehold" and helping research institutions reduce costs and increase efficiency. Bioford™️, as an AI foundation, is reshaping the underlying logic of bioscience research, bringing the wave of technological innovation to a wider range of researchers and industry partners!
Decoding the Future of Life, Defining a New Era of Biological Intelligence
Beyond the CCTV lens, GeneLLM™️, at the forefront of the gene cognition revolution, is using AI as a pen to write a new narrative in the code of life. In the future, with the deepening of cross-species computing frameworks and the expansion of industrial application scenarios, this core technology will break through the boundaries of traditional biology:
In synthetic biology, it will become a "gene scissors" for customizing life components;
In the agricultural breeding revolution, it will transform into a "digital breeder" accelerating crop evolution;
On the environmental governance battlefield, it will build an "environmental brain" for micro-ecological monitoring.
……
With the 6-billion-parameter large model and the Bioford™️ platform ecosystem resonance, we not only compress millions of molecular experiments into second-level computations but also help China seize strategic high ground in the global bioeconomy restructuring, achieving a historic leap from "follower" to "rule-maker." This AI-driven life science revolution is reshaping the underlying logic of human exploration of life's mysteries, leading us into a bright future of intelligent biology.